{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:28:06Z","timestamp":1794547686544,"version":"4.9.1"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018934","name":"Universit\u00e4t Greifswald","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018934","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The 5-lipoxygenase-activating protein (FLAP) is an integral membrane protein that is essential for 5-lipoxygenase-mediated leukotriene formation, thereby playing a key role in inflammation and serving as a potential therapeutic target. For over 30\u00a0years, researchers have been elucidating the crystal structure, identifying the inhibitor binding site, and developing several potent inhibitors, which have been investigated in preclinical and clinical studies to treat asthma, chronic kidney and cardiovascular diseases. However, despite being almost overlooked, more than 20,000 single nucleotide polymorphisms (SNPs) were detected in the\n                    <jats:italic>ALOX5AP<\/jats:italic>\n                    gene, coding for FLAP. To date, 66 SNPs have been studied in relation to a disease by different researchers, including different population groups. This review aims to synthesize current evidence on genetic variants of FLAP and delineate single SNPs that have been primarily implicated in coronary artery disease, myocardial infarction, and ischemic stroke. Associations between SNPs of\n                    <jats:italic>ALOX5AP<\/jats:italic>\n                    and these diseases have been reported, but findings remain inconsistent due to differences in study design, population diversity and methodological approaches. Although meta-analyses helped to integrate the results of different studies, they remain limited due to underlying differences and cannot provide a definitive conclusion.\n                  <\/jats:p>","DOI":"10.1186\/s40246-025-00867-x","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T08:57:25Z","timestamp":1765616245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetic insights into 5-LOX-activating protein: a narrative review of disease associations"],"prefix":"10.1186","volume":"20","author":[{"given":"Katharina","family":"Rataj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Garscha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"867_CR1","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1021\/cr200246d","volume":"111","author":"JZ Haeggstr\u00f6m","year":"2011","unstructured":"Haeggstr\u00f6m JZ, Funk CD. Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem Rev. 2011;111:5866\u201398. https:\/\/doi.org\/10.1021\/cr200246d.","journal-title":"Chem Rev"},{"key":"867_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.pharmtox.011008.145616","volume":"49","author":"T Shimizu","year":"2009","unstructured":"Shimizu T. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu Rev Pharmacol Toxicol. 2009;49:123\u201350. https:\/\/doi.org\/10.1146\/annurev.pharmtox.011008.145616.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"867_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1538\/expanim.60.7","volume":"60","author":"M Murakami","year":"2011","unstructured":"Murakami M. Lipid mediators in life science. Exp Anim. 2011;60:7\u201320. https:\/\/doi.org\/10.1538\/expanim.60.7.","journal-title":"Exp Anim"},{"key":"867_CR4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nri3859","volume":"15","author":"EA Dennis","year":"2015","unstructured":"Dennis EA, Norris PC. Eicosanoid storm in infection and inflammation. Nat Rev Immunol. 2015;15:511\u201323. https:\/\/doi.org\/10.1038\/nri3859.","journal-title":"Nat Rev Immunol"},{"key":"867_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbalip.2014.08.012","volume":"1851","author":"O R\u00e5dmark","year":"2015","unstructured":"R\u00e5dmark O, Werz O, Steinhilber D, Samuelsson B. 5-lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease. Biochim Biophys Acta. 2015;1851:331\u20139. https:\/\/doi.org\/10.1016\/j.bbalip.2014.08.012.","journal-title":"Biochim Biophys Acta"},{"key":"867_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev-pharmtox-051921-085014","volume":"63","author":"JZ Haeggstr\u00f6m","year":"2023","unstructured":"Haeggstr\u00f6m JZ, Newcomer ME. Structures of leukotriene biosynthetic enzymes and development of new therapeutics. Annu Rev Pharmacol Toxicol. 2023;63:407\u201328. https:\/\/doi.org\/10.1146\/annurev-pharmtox-051921-085014.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"867_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tips.2007.11.006","volume":"29","author":"JF Evans","year":"2008","unstructured":"Evans JF, Ferguson AD, Mosley RT, Hutchinson JH. What\u2019s all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases. Trends Pharmacol Sci. 2008;29:72\u20138. https:\/\/doi.org\/10.1016\/j.tips.2007.11.006.","journal-title":"Trends Pharmacol Sci"},{"key":"867_CR8","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1016\/j.bbagen.2014.05.016","volume":"1840","author":"J Gerstmeier","year":"2014","unstructured":"Gerstmeier J, Weinigel C, Barz D, Werz O, Garscha U. An experimental cell-based model for studying the cell biology and molecular pharmacology of 5-lipoxygenase-activating protein in leukotriene biosynthesis. Biochim Biophys Acta. 2014;1840:2961\u20139. https:\/\/doi.org\/10.1016\/j.bbagen.2014.05.016.","journal-title":"Biochim Biophys Acta"},{"key":"867_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/343282a0","volume":"343","author":"RAF Dixon","year":"1990","unstructured":"Dixon RAF, Diehl RE, Opas E, Rands E, Vickers PJ, Evans JF, et al. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature. 1990;343:282\u20134. https:\/\/doi.org\/10.1038\/343282a0.","journal-title":"Nature"},{"key":"867_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11882-008-0057-z","volume":"8","author":"M Peters-Golden","year":"2008","unstructured":"Peters-Golden M. Expanding roles for leukotrienes in airway inflammation. Curr Allergy Asthma Rep. 2008;8:367\u201373. https:\/\/doi.org\/10.1007\/s11882-008-0057-z.","journal-title":"Curr Allergy Asthma Rep"},{"key":"867_CR11","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/S0021-9258(19)40034-3","volume":"265","author":"CA Rouzer","year":"1990","unstructured":"Rouzer CA, Ford-Hutchinson AW, Morton HE, Gillard JW. MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. J Biol Chem. 1990;265:1436\u201342.","journal-title":"J Biol Chem"},{"key":"867_CR12","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/343278a0","volume":"343","author":"DK Miller","year":"1990","unstructured":"Miller DK, Gillard JW, Vickers PJ, Sadowski S, L\u00e9veill\u00e9 C, Mancini JA, et al. Identification and isolation of a membrane protein necessary for leukotriene production. Nature. 1990;343:278\u201381. https:\/\/doi.org\/10.1038\/343278a0.","journal-title":"Nature"},{"key":"867_CR13","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-5","volume":"161","author":"PJ Jakobsson","year":"2000","unstructured":"Jakobsson PJ, Morgenstern R, Mancini J, Ford-Hutchinson A, Persson B. Membrane-associated proteins in eicosanoid and glutathione metabolism (MAPEG) A widespread protein superfamily. Am J Respir Crit Care Med. 2000;161:S20-24. https:\/\/doi.org\/10.1164\/ajrccm.161.supplement_1.ltta-5.","journal-title":"Am J Respir Crit Care Med"},{"key":"867_CR14","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1139\/y92-107","volume":"70","author":"C Brideau","year":"1992","unstructured":"Brideau C, Chan C, Charleson S, Denis D, Evans JF, Ford-Hutchinson AW, et al. Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)-indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol. 1992;70:799\u2013807. https:\/\/doi.org\/10.1139\/y92-107.","journal-title":"Can J Physiol Pharmacol"},{"key":"867_CR15","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0026-895X(25)09139-4","volume":"41","author":"S Charleson","year":"1992","unstructured":"Charleson S, Prasit P, L\u00e9ger S, Gillard JW, Vickers PJ, Mancini JA, et al. Characterization of a 5-lipoxygenase-activating protein binding assay: correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibition. Mol Pharmacol. 1992;41:873\u20139. https:\/\/doi.org\/10.1016\/S0026-895X(25)09139-4.","journal-title":"Mol Pharmacol"},{"key":"867_CR16","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.bbalip.2015.08.010","volume":"1851","author":"AK H\u00e4fner","year":"2015","unstructured":"H\u00e4fner AK, Gerstmeier J, H\u00f6rnig M, George S, Ball AK, Schr\u00f6der M, et al. Characterization of the interaction of human 5-lipoxygenase with its activating protein FLAP. Biochim Biophys Acta. 2015;1851:1465\u201372. https:\/\/doi.org\/10.1016\/j.bbalip.2015.08.010.","journal-title":"Biochim Biophys Acta"},{"key":"867_CR17","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1002\/1873-3468.70066","volume":"599","author":"E Romp","year":"2025","unstructured":"Romp E, Rataj K, K\u00f6nig S, Newcomer ME, Werz O, Garscha U. Modifications in FLAP\u2019s second cytosolic loop influence 5-LOX interaction, inhibitor binding, and leukotriene formation. FEBS Lett. 2025;599:2179\u201389. https:\/\/doi.org\/10.1002\/1873-3468.70066.","journal-title":"FEBS Lett"},{"key":"867_CR18","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1126\/science.1144346","volume":"317","author":"AD Ferguson","year":"2007","unstructured":"Ferguson AD, McKeever BM, Xu S, Wisniewski D, Miller DK, Yamin TT, et al. Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein. Science. 2007;317:510\u20132. https:\/\/doi.org\/10.1126\/science.1144346.","journal-title":"Science"},{"key":"867_CR19","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1021\/acs.jmedchem.8b02004","volume":"62","author":"D Pettersen","year":"2019","unstructured":"Pettersen D, Broddefalk J, Emten\u00e4s H, Hayes MA, Lemurell M, Swanson M, et al. Discovery and early clinical development of an inhibitor of 5-lipoxygenase activating protein (AZD5718) for treatment of coronary artery disease. J Med Chem. 2019;62:4312\u201324. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b02004.","journal-title":"J Med Chem"},{"key":"867_CR20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/cpdd.756","volume":"9","author":"H Ericsson","year":"2020","unstructured":"Ericsson H, Nelander K, Heijer M, Kjaer M, Lindstedt EL, Albayaty M, et al. Phase 1 Pharmacokinetic Study of AZD5718 in Healthy Volunteers: Effects of Coadministration With Rosuvastatin Formulation and Food on Oral Bioavailability. Clin Pharmacol Drug Dev. 2020;9:411\u201321. https:\/\/doi.org\/10.1002\/cpdd.756.","journal-title":"Clin Pharmacol Drug Dev"},{"key":"867_CR21","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1021\/acs.jmedchem.8b02012","volume":"62","author":"M Lemurell","year":"2019","unstructured":"Lemurell M, Ulander J, Emten\u00e4s H, Winiwarter S, Broddefalk J, Swanson M, et al. Novel chemical series of 5-lipoxygenase-activating protein inhibitors for treatment of coronary artery disease. J Med Chem. 2019;62:4325\u201349. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b02012.","journal-title":"J Med Chem"},{"key":"867_CR22","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1016\/j.ekir.2021.08.018","volume":"6","author":"HJL Heerspink","year":"2021","unstructured":"Heerspink HJL, Law G, Psachoulia K, Connolly K, Whatling C, Ericsson H, et al. Design of FLAIR: a phase 2b study of the 5-lipoxygenase activating protein inhibitor AZD5718 in patients with proteinuric CKD. Kidney Int Rep. 2021;6:2803\u201310. https:\/\/doi.org\/10.1016\/j.ekir.2021.08.018.","journal-title":"Kidney Int Rep"},{"key":"867_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.pupt.2013.11.007","volume":"27","author":"R Chaudhuri","year":"2014","unstructured":"Chaudhuri R, Norris V, Kelly K, Zhu CQ, Ambery C, Lafferty J, et al. Effects of a FLAP inhibitor, GSK2190915, in asthmatics with high sputum neutrophils. Pulm Pharmacol Ther. 2014;27:62\u20139. https:\/\/doi.org\/10.1016\/j.pupt.2013.11.007.","journal-title":"Pulm Pharmacol Ther"},{"key":"867_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12944-019-0968-9","volume":"18","author":"Y Li","year":"2019","unstructured":"Li Y, Xu X, Zhang D, Cheng W, Zhang Y, Yu B, et al. Genetic variation in the leukotriene pathway is associated with myocardial infarction in the Chinese population. Lipids Health Dis. 2019;18:25. https:\/\/doi.org\/10.1186\/s12944-019-0968-9.","journal-title":"Lipids Health Dis"},{"key":"867_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00011-015-0821-1","volume":"64","author":"M Merhi","year":"2015","unstructured":"Merhi M, Demirdjian S, Hariri E, Sabbah N, Youhanna S, Ghassibe-Sabbagh M, et al. Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk. Inflamm Res. 2015;64:415\u201322. https:\/\/doi.org\/10.1007\/s00011-015-0821-1.","journal-title":"Inflamm Res"},{"key":"867_CR26","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/wnr.0000000000000114","volume":"25","author":"LF Chi","year":"2014","unstructured":"Chi LF, Yi XY, Shao MJ, Lin J, Zhou Q. Interaction between ALOX5AP and CYP3A5 gene variants significantly increases the risk for cerebral infarctions in Chinese. NeuroReport. 2014;25:452\u20137. https:\/\/doi.org\/10.1097\/wnr.0000000000000114.","journal-title":"NeuroReport"},{"key":"867_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1006\/geno.1998.5651","volume":"56","author":"CN Yandava","year":"1999","unstructured":"Yandava CN, Kennedy BP, Pillari A, Duncan AM, Drazen JM. Cytogenetic and radiation hybrid mapping of human arachidonate 5-lipoxygenase-activating protein (ALOX5AP) to chromosome 13q12. Genomics. 1999;56:131\u20133. https:\/\/doi.org\/10.1006\/geno.1998.5651.","journal-title":"Genomics"},{"key":"867_CR28","doi-asserted-by":"publisher","first-page":"8511","DOI":"10.1016\/S0021-9258(18)93004-8","volume":"266","author":"BP Kennedy","year":"1991","unstructured":"Kennedy BP, Diehl RE, Boie Y, Adam M, Dixon RA. Gene characterization and promoter analysis of the human 5-lipoxygenase-activating protein (FLAP). J Biol Chem. 1991;266:8511\u20136.","journal-title":"J Biol Chem"},{"key":"867_CR29","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1093\/nar\/gkf466","volume":"30","author":"BW Kirk","year":"2002","unstructured":"Kirk BW, Feinsod M, Favis R, Kliman RM, Barany F. Single nucleotide polymorphism seeking long term association with complex disease. Nucleic Acids Res. 2002;30:3295\u2013311. https:\/\/doi.org\/10.1093\/nar\/gkf466.","journal-title":"Nucleic Acids Res"},{"key":"867_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-60327-411-1_1","volume":"578","author":"BS Shastry","year":"2009","unstructured":"Shastry BS. SNPs: impact on gene function and phenotype. Methods Mol Biol. 2009;578:3\u201322. https:\/\/doi.org\/10.1007\/978-1-60327-411-1_1.","journal-title":"Methods Mol Biol"},{"key":"867_CR31","doi-asserted-by":"publisher","first-page":"R102","DOI":"10.1093\/hmg\/ddv259","volume":"24","author":"F Zhang","year":"2015","unstructured":"Zhang F, Lupski JR. Non-coding genetic variants in human disease. Hum Mol Genet. 2015;24:R102\u201310. https:\/\/doi.org\/10.1093\/hmg\/ddv259.","journal-title":"Hum Mol Genet"},{"key":"867_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0027-5107(03)00014-9","volume":"526","author":"BA Salisbury","year":"2003","unstructured":"Salisbury BA, Pungliya M, Choi JY, Jiang R, Sun XJ, Stephens JC. Snp and haplotype variation in the human genome. Mutat Res-Fundam Mol Mech Mutagen. 2003;526:53\u201361. https:\/\/doi.org\/10.1016\/S0027-5107(03)00014-9.","journal-title":"Mutat Res-Fundam Mol Mech Mutagen"},{"key":"867_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40246-023-00513-4","volume":"17","author":"C Zhu","year":"2023","unstructured":"Zhu C, Baumgarten N, Wu M, Wang Y, Das AP, Kaur J, et al. CVD-associated SNPs with regulatory potential reveal novel non-coding disease genes. Hum Genomics. 2023;17:69. https:\/\/doi.org\/10.1186\/s40246-023-00513-4.","journal-title":"Hum Genomics"},{"key":"867_CR34","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1474-4422(12)70234-X","volume":"11","author":"M Traylor","year":"2012","unstructured":"Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell JC, Cheng Y-C, et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol. 2012;11:951\u201362. https:\/\/doi.org\/10.1016\/S1474-4422(12)70234-X.","journal-title":"Lancet Neurol"},{"key":"867_CR35","doi-asserted-by":"publisher","first-page":"16812","DOI":"10.1002\/jcp.28350","volume":"234","author":"AK Malakar","year":"2019","unstructured":"Malakar AK, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019;234:16812\u201323. https:\/\/doi.org\/10.1002\/jcp.28350.","journal-title":"J Cell Physiol"},{"key":"867_CR36","unstructured":"R.D. Shahjehan, B.S. Bhutta, Coronary Artery Disease, StatPearls, StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC., Treasure Island (FL), 2024."},{"key":"867_CR37","doi-asserted-by":"publisher","first-page":"29513","DOI":"10.1038\/srep29513","volume":"6","author":"D Yang","year":"2016","unstructured":"Yang D, Huang X, Cui C, Zhang Y, Li Y, Zang X, et al. Genetic variants in the transcriptional regulatory region of the ALOX5AP gene and susceptibility to ischemic stroke in Chinese populations. Sci Rep. 2016;6:29513. https:\/\/doi.org\/10.1038\/srep29513.","journal-title":"Sci Rep"},{"key":"867_CR38","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2147\/ndt.S182674","volume":"15","author":"JH Zheng","year":"2019","unstructured":"Zheng JH, Ning GL, Xu WH, Wu XC, Ma XC. Lack of association between ALOX5AP genetic polymorphisms and risk of ischemic stroke: evidence from meta-analyses. Neuropsychiatr Dis Treat. 2019;15:357\u201367. https:\/\/doi.org\/10.2147\/ndt.S182674.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"867_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00439-011-0963-3","volume":"129","author":"J Hartiala","year":"2011","unstructured":"Hartiala J, Li D, Conti DV, Vikman S, Patel Y, Tang WH, et al. Genetic contribution of the leukotriene pathway to coronary artery disease. Hum Genet. 2011;129:617\u201327. https:\/\/doi.org\/10.1007\/s00439-011-0963-3.","journal-title":"Hum Genet"},{"key":"867_CR40","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1161\/strokeaha.108.525733","volume":"40","author":"S Bevan","year":"2009","unstructured":"Bevan S, Lorenz MW, Sitzer M, Markus HS. Genetic variation in the leukotriene pathway and carotid intima-media thickness: a 2-stage replication study. Stroke. 2009;40:696\u2013701. https:\/\/doi.org\/10.1161\/strokeaha.108.525733.","journal-title":"Stroke"},{"key":"867_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001146","volume":"6","author":"S Okser","year":"2010","unstructured":"Okser S, Lehtim\u00e4ki T, Elo LL, Mononen N, Peltonen N, K\u00e4h\u00f6nen M, et al. Genetic variants and their interactions in the prediction of increased pre-clinical carotid atherosclerosis: the cardiovascular risk in young Finns study. PLoS Genet. 2010;6:e1001146. https:\/\/doi.org\/10.1371\/journal.pgen.1001146.","journal-title":"PLoS Genet"},{"key":"867_CR42","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.atherosclerosis.2008.01.011","volume":"201","author":"SH Shah","year":"2008","unstructured":"Shah SH, Hauser ER, Crosslin D, Wang L, Haynes C, Connelly J, et al. ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention. Atherosclerosis. 2008;201:148\u201354. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.01.011.","journal-title":"Atherosclerosis"},{"key":"867_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167217","volume":"11","author":"A Gammelmark","year":"2016","unstructured":"Gammelmark A, Nielsen MS, Lundbye-Christensen S, Tj\u00f8nneland A, Schmidt EB, Overvad K. Common polymorphisms in the 5-lipoxygenase pathway and risk of incident myocardial infarction: a Danish case-cohort study. PLoS ONE. 2016;11:e0167217. https:\/\/doi.org\/10.1371\/journal.pone.0167217.","journal-title":"PLoS ONE"},{"key":"867_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-2350-13-61","volume":"13","author":"SY Zhang","year":"2012","unstructured":"Zhang SY, Xu ML, Zhang CE, Qu ZY, Zhang BB, Zheng ZY, et al. Association of ALOX5AP gene single nucleotide polymorphisms and cerebral infarction in the Han population of northern China. BMC Med Genet. 2012;13:61. https:\/\/doi.org\/10.1186\/1471-2350-13-61.","journal-title":"BMC Med Genet"},{"key":"867_CR45","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/rheumatology\/kew499","volume":"56","author":"O Kowal-Bielecka","year":"2017","unstructured":"Kowal-Bielecka O, Chwiesko-Minarowska S, Bernatowicz PL, Allanore Y, Radstake T, Matucci-Cerinic M, et al. The arachidonate 5-lipoxygenase activating protein gene polymorphism is associated with the risk of scleroderma-related interstitial lung disease: a multicentre European Scleroderma Trials and Research group (EUSTAR) study. Rheumatology (Oxford). 2017;56:844\u201352. https:\/\/doi.org\/10.1093\/rheumatology\/kew499.","journal-title":"Rheumatology (Oxford)"},{"key":"867_CR46","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/PSY.0b013e3181b05c57","volume":"71","author":"J Zhao","year":"2009","unstructured":"Zhao J, Quyyumi AA, Patel R, Zafari AM, Veledar E, Onufrak S, et al. Sex-specific association of depression and a haplotype in leukotriene A4 hydrolase gene. Psychosom Med. 2009;71:691\u20136. https:\/\/doi.org\/10.1097\/PSY.0b013e3181b05c57.","journal-title":"Psychosom Med"},{"key":"867_CR47","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.atherosclerosis.2009.02.019","volume":"206","author":"DM Oosterveer","year":"2009","unstructured":"Oosterveer DM, Versmissen J, Yazdanpanah M, van der Net JB, Defesche JC, Kastelein JJ, et al. 5-lipoxygenase activating protein (ALOX5AP) gene variants associate with the presence of xanthomas in familial hypercholesterolemia. Atherosclerosis. 2009;206:223\u20137. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.02.019.","journal-title":"Atherosclerosis"},{"key":"867_CR48","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.arcmed.2010.11.001","volume":"41","author":"H Huang","year":"2010","unstructured":"Huang H, Zeng Z, Li J, Zhang L, Chen Y. Variants of Arachidonate 5-Lipoxygenase-activating protein (ALOX5AP) gene and risk of coronary heart disease: a meta-analysis. Arch Med Res. 2010;41:634\u201341. https:\/\/doi.org\/10.1016\/j.arcmed.2010.11.001.","journal-title":"Arch Med Res"},{"key":"867_CR49","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1042\/cs20070468","volume":"115","author":"P Linsel-Nitschke","year":"2008","unstructured":"Linsel-Nitschke P, G\u00f6tz A, Medack A, K\u00f6nig IR, Bruse P, Lieb W, et al. Genetic variation in the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) is associated with myocardial infarction in the German population. Clin Sci Lond. 2008;115:309\u201315. https:\/\/doi.org\/10.1042\/cs20070468.","journal-title":"Clin Sci Lond"},{"key":"867_CR50","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jns.2007.06.042","volume":"263","author":"K Kostulas","year":"2007","unstructured":"Kostulas K, Gretarsdottir S, Kostulas V, Manolescu A, Helgadottir A, Thorleifsson G, et al. PDE4D and ALOX5AP genetic variants and risk for ischemic cerebrovascular disease in Sweden. J Neurol Sci. 2007;263:113\u20137. https:\/\/doi.org\/10.1016\/j.jns.2007.06.042.","journal-title":"J Neurol Sci"},{"key":"867_CR51","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/abbs\/gms088","volume":"44","author":"J Zhao","year":"2012","unstructured":"Zhao J, Wang X, Xu J, Li N, Shang X, He Z, et al. Association of inflammatory response gene polymorphism with atherothrombotic stroke in Northern Han Chinese. Acta Biochim Biophys Sin (Shanghai). 2012;44:1023\u201330. https:\/\/doi.org\/10.1093\/abbs\/gms088.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"867_CR52","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.atherosclerosis.2009.06.018","volume":"207","author":"AK Tsai","year":"2009","unstructured":"Tsai AK, Li N, Hanson NQ, Tsai MY, Tang W. Associations of genetic polymorphisms of arachidonate 5-lipoxygenase-activating protein with risk of coronary artery disease in a European-American population. Atherosclerosis. 2009;207:487\u201391. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.06.018.","journal-title":"Atherosclerosis"},{"key":"867_CR53","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.jocn.2011.03.035","volume":"18","author":"JD Lee","year":"2011","unstructured":"Lee JD, Lee TH, Huang YC, Chang YJ, Chang CH, Hsu HL, et al. ALOX5AP genetic variants and risk of atherothrombotic stroke in the Taiwanese population. J Clin Neurosci. 2011;18:1634\u20138. https:\/\/doi.org\/10.1016\/j.jocn.2011.03.035.","journal-title":"J Clin Neurosci"},{"key":"867_CR54","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00439-008-0619-0","volume":"125","author":"DR Crosslin","year":"2009","unstructured":"Crosslin DR, Shah SH, Nelson SC, Haynes CS, Connelly JJ, Gadson S, et al. Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis. Hum Genet. 2009;125:217\u201329. https:\/\/doi.org\/10.1007\/s00439-008-0619-0.","journal-title":"Hum Genet"},{"key":"867_CR55","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.iccl.2015.12.006","volume":"5","author":"MS Lee","year":"2016","unstructured":"Lee MS, Banka G. In-stent restenosis. Interv Cardiol Clin. 2016;5:211\u201320. https:\/\/doi.org\/10.1016\/j.iccl.2015.12.006.","journal-title":"Interv Cardiol Clin"},{"key":"867_CR56","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.36740\/WLek202011118","volume":"73","author":"OU Pavlenko","year":"2020","unstructured":"Pavlenko OU, Strokina IG, Drevytska TI, Sokurenko LM, Dosenko VE. Association between single polymorphism in the locus rs17216473 of the gene that encodes 5-lipoxygenase-activating protein and risk of myocardial infarction. Wiad Lek. 2020;73:2431\u20137.","journal-title":"Wiad Lek"},{"key":"867_CR57","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12872-015-0128-8","volume":"15","author":"L Pleva","year":"2015","unstructured":"Pleva L, Kovarova P, Faldynova L, Plevova P, Hilscherova S, Zapletalova J, et al. The rs1803274 polymorphism of the BCHE gene is associated with an increased risk of coronary in-stent restenosis. BMC Cardiovasc Disord. 2015;15:135. https:\/\/doi.org\/10.1186\/s12872-015-0128-8.","journal-title":"BMC Cardiovasc Disord"},{"key":"867_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224089","volume":"14","author":"M Bachtiar","year":"2019","unstructured":"Bachtiar M, Jin Y, Wang J, Tan TW, Chong SS, Ban KHK, et al. Architecture of population-differentiated polymorphisms in the human genome. PLoS ONE. 2019;14:e0224089. https:\/\/doi.org\/10.1371\/journal.pone.0224089.","journal-title":"PLoS ONE"},{"key":"867_CR59","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2350-9-21","volume":"9","author":"H Al-Shemari","year":"2008","unstructured":"Al-Shemari H, Boss\u00e9 Y, Hudson TJ, Cabaluna M, Duval M, Lemire M, et al. Influence of leukotriene gene polymorphisms on chronic rhinosinusitis. BMC Med Genet. 2008;9:21. https:\/\/doi.org\/10.1186\/1471-2350-9-21.","journal-title":"BMC Med Genet"},{"key":"867_CR60","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1158\/1055-9965.Epi-08-0439","volume":"17","author":"J Wang","year":"2008","unstructured":"Wang J, John EM, Ingles SA. 5-lipoxygenase and 5-lipoxygenase-activating protein gene polymorphisms, dietary linoleic acid, and risk for breast cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:2748\u201354. https:\/\/doi.org\/10.1158\/1055-9965.Epi-08-0439.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"867_CR61","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/pros.21354","volume":"71","author":"ES Amirian","year":"2011","unstructured":"Amirian ES, Ittmann MM, Scheurer ME. Associations between arachidonic acid metabolism gene polymorphisms and prostate cancer risk. Prostate. 2011;71:1382\u20139. https:\/\/doi.org\/10.1002\/pros.21354.","journal-title":"Prostate"},{"key":"867_CR62","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s10072-018-3489-9","volume":"39","author":"Y Shi","year":"2018","unstructured":"Shi Y, Xu L, Feng Q, Li A, Jia J, Xu Y, et al. Allele-specific methylation contributed by CpG-SNP is associated with regulation of ALOX5AP gene expression in ischemic stroke. Neurol Sci. 2018;39:1717\u201324. https:\/\/doi.org\/10.1007\/s10072-018-3489-9.","journal-title":"Neurol Sci"},{"key":"867_CR63","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.clineuro.2014.01.004","volume":"119","author":"R Zhang","year":"2014","unstructured":"Zhang R, Guo X, Li X, Liu W, Peng Y, Han X, et al. Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene rs4073259 polymorphism not associated with ischemic stroke in the northeastern Chinese Han population. Clin Neurol Neurosurg. 2014;119:64\u20139. https:\/\/doi.org\/10.1016\/j.clineuro.2014.01.004.","journal-title":"Clin Neurol Neurosurg"},{"key":"867_CR64","first-page":"114","volume":"18","author":"M Erfani","year":"2019","unstructured":"Erfani M, Sadr-Nabavi A, Jafarzadeh-Esfehani R, Shariati M, Ghanbari-Garekani L, Vojdani-Chahchaheh S, et al. Association of 5-lipoxygenase activating protein gene polymorphism and stroke: a study from north east of Iran. Iran J Neurol. 2019;18:114\u20138.","journal-title":"Iran J Neurol"},{"key":"867_CR65","first-page":"29","volume":"14","author":"AB Haidich","year":"2010","unstructured":"Haidich AB. Meta-analysis in medical research. Hippokratia. 2010;14:29\u201337.","journal-title":"Hippokratia"},{"key":"867_CR66","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000012682","volume":"97","author":"H Ye","year":"2018","unstructured":"Ye H, Zhang X, Chen Z, Li X, Zhang T, Yang C, et al. Association between the polymorphism (rs17222919, -1316T\/G) of 5-lipoxygenase-activating protein gene (ALOX5AP) and the risk of stroke: a meta analysis. Medicine (Baltimore). 2018;97:e12682. https:\/\/doi.org\/10.1097\/md.0000000000012682.","journal-title":"Medicine (Baltimore)"},{"key":"867_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122393","volume":"10","author":"Y Fan","year":"2015","unstructured":"Fan Y, Chen H, Li A, Shi Y, Zhang Y, Feng Q, et al. A promoter polymorphism (rs17222919, -1316T\/G) of ALOX5AP gene is associated with decreased risk of ischemic stroke in two independent Chinese populations. PLoS ONE. 2015;10:e0122393. https:\/\/doi.org\/10.1371\/journal.pone.0122393.","journal-title":"PLoS ONE"},{"key":"867_CR68","doi-asserted-by":"publisher","first-page":"108","DOI":"10.5847\/wjem.j.issn.1920-8642.2012.02.005","volume":"3","author":"Y Wang","year":"2012","unstructured":"Wang Y, Wang GN, Sun H, Chen C, Xiao H, Zhang JS. Association of ALOX5AP with ischemic stroke in eastern Chinese. World J Emerg Med. 2012;3:108\u201313. https:\/\/doi.org\/10.5847\/wjem.j.issn.1920-8642.2012.02.005.","journal-title":"World J Emerg Med"},{"key":"867_CR69","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00439-007-0338-y","volume":"121","author":"R Kaushal","year":"2007","unstructured":"Kaushal R, Pal P, Alwell K, Haverbusch M, Flaherty M, Moomaw C, et al. Association of ALOX5AP with ischemic stroke: a population-based case-control study. Hum Genet. 2007;121:601\u20137. https:\/\/doi.org\/10.1007\/s00439-007-0338-y.","journal-title":"Hum Genet"},{"key":"867_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112279","volume":"9","author":"L Ib\u00e1\u00f1ez","year":"2014","unstructured":"Ib\u00e1\u00f1ez L, Velli PS, Font R, Ja\u00e9n A, Royo J, Irigoyen D, et al. HIV-infection, atherosclerosis and the inflammatory pathway: candidate gene study in a Spanish HIV-infected population. PLoS ONE. 2014;9:e112279. https:\/\/doi.org\/10.1371\/journal.pone.0112279.","journal-title":"PLoS ONE"},{"key":"867_CR71","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3109\/00207454.2014.967769","volume":"125","author":"X Ke","year":"2015","unstructured":"Ke X, Wu X, Guo H, Li Q. Association of ALOX5AP rs10507391\/SG13S114 A>T polymorphism with cerebral infarction in the Chinese population: a meta-analysis study. Int J Neurosci. 2015;125:726\u201332. https:\/\/doi.org\/10.3109\/00207454.2014.967769.","journal-title":"Int J Neurosci"},{"issue":"629","key":"867_CR72","doi-asserted-by":"publisher","first-page":"e621","DOI":"10.1016\/j.neurobiolaging.2011.10.010","volume":"33","author":"S Barral","year":"2012","unstructured":"Barral S, Fern\u00e1ndez-Cadenas I, Bis JC, Montaner J, Ikram AM, Launer LJ, et al. No association of ALOX5AP polymorphisms with risk of MRI-defined brain infarcts. Neurobiol Aging. 2012;33(629):e621-623. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.10.010.","journal-title":"Neurobiol Aging"},{"key":"867_CR73","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/s1674-8301(11)60043-2","volume":"25","author":"G Wang","year":"2011","unstructured":"Wang G, Wang Y, Sun H, Cao W, Zhang J, Xiao H, et al. Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of ischemic stroke in Han Chinese of eastern China. J Biomed Res. 2011;25:319\u201327. https:\/\/doi.org\/10.1016\/s1674-8301(11)60043-2.","journal-title":"J Biomed Res"},{"key":"867_CR74","first-page":"570","volume":"47","author":"EA Bondarenko","year":"2011","unstructured":"Bondarenko EA, Slominski\u012d PA, Limborskaia SA, Shetova IM, Timofeev DY, Skvortsova VI. Polymorphic variants of ALOX5AP gene and the risk of acute stroke development in the Russian population. Genetika. 2011;47:570\u20133.","journal-title":"Genetika"},{"key":"867_CR75","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s12013-013-9579-7","volume":"67","author":"C Xu","year":"2013","unstructured":"Xu C, Qiang L, Limei C, Yan Z, Jia Z, Zhiqiang D, et al. Correlation between cerebral infarction and ALOX5AP gene expression. Cell Biochem Biophys. 2013;67:899\u2013904. https:\/\/doi.org\/10.1007\/s12013-013-9579-7.","journal-title":"Cell Biochem Biophys"},{"key":"867_CR76","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jfma.2013.12.004","volume":"114","author":"M Shao","year":"2015","unstructured":"Shao M, Yi X, Chi L, Lin J, Zhou Q, Huang R. Ischemic stroke risk in a southeastern Chinese population: insights from 5-lipoxygenase activating protein and phosphodiesterase 4D single-nucleotide polymorphisms. J Formos Med Assoc. 2015;114:422\u20139. https:\/\/doi.org\/10.1016\/j.jfma.2013.12.004.","journal-title":"J Formos Med Assoc"},{"key":"867_CR77","doi-asserted-by":"publisher","first-page":"137","DOI":"10.14715\/cmb\/2017.63.10.22","volume":"63","author":"KL Li","year":"2017","unstructured":"Li KL, Chen CY, Xu M, Zhu XQ, Yang XJ. ALOX5AP rs10507391 polymorphism and the risk of ischemic stroke in Caucasians: an update meta-analysis. Cell Mol Biol (Noisy-le-grand). 2017;63:137\u201340. https:\/\/doi.org\/10.14715\/cmb\/2017.63.10.22.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"867_CR78","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1159\/000302738","volume":"29","author":"S Domingues-Montanari","year":"2010","unstructured":"Domingues-Montanari S, Fern\u00e1ndez-Cadenas I, del Rio-Espinola A, Corbeto N, Krug T, Manso H, et al. Association of a genetic variant in the ALOX5AP with higher risk of ischemic stroke: a case-control, meta-analysis and functional study. Cerebrovasc Dis. 2010;29:528\u201337. https:\/\/doi.org\/10.1159\/000302738.","journal-title":"Cerebrovasc Dis"},{"key":"867_CR79","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jocn.2013.08.023","volume":"21","author":"Q Yao","year":"2014","unstructured":"Yao Q, Zhang C, Zhang X, Yuan R, Li J, Sun F, et al. Synergistic effect of ALOX5AP polymorphisms and cigarette smoking on the risk of atherosclerotic cerebral infarction in a Northern Han Chinese population. J Clin Neurosci. 2014;21:975\u20139. https:\/\/doi.org\/10.1016\/j.jocn.2013.08.023.","journal-title":"J Clin Neurosci"},{"key":"867_CR80","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1007\/s11033-010-0610-4","volume":"38","author":"H Sun","year":"2011","unstructured":"Sun H, Wu H, Zhang J, Wang J, Lu Y, Ding H, et al. A tagging SNP in ALOX5AP and risk of stroke: a haplotype-based analysis among eastern Chinese Han population. Mol Biol Rep. 2011;38:4731\u20138. https:\/\/doi.org\/10.1007\/s11033-010-0610-4.","journal-title":"Mol Biol Rep"},{"key":"867_CR81","first-page":"21343","volume":"8","author":"Z Qu","year":"2015","unstructured":"Qu Z, Su F, Zhu Y, Zhang S, Zhao H, Li Y, et al. A tagging ALOX5AP polymorphism and risk of ischemic stroke in a northeastern Chinese Han population. Int J Clin Exp Med. 2015;8:21343\u201350.","journal-title":"Int J Clin Exp Med"},{"key":"867_CR82","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.09.035","volume":"24","author":"X Yi","year":"2015","unstructured":"Yi X, Zhang B, Wang C, Liao D, Lin J, Chi L. Genetic polymorphisms of ALOX5AP and CYP3A5 increase susceptibility to ischemic stroke and are associated with atherothrombotic events in stroke patients. J Stroke Cerebrovasc Dis. 2015;24:521\u20139. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2014.09.035.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"867_CR83","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.4238\/2013.May.14.6","volume":"12","author":"XY Yi","year":"2013","unstructured":"Yi XY, Zhou Q, Lin J, Chi LF, Chi WZ. Interaction between ALOX5AP-SG13S114A\/T and COX-2-765G\/C increases susceptibility to cerebral infarction in a Chinese population. Genet Mol Res. 2013;12:1660\u20139. https:\/\/doi.org\/10.4238\/2013.May.14.6.","journal-title":"Genet Mol Res"},{"key":"867_CR84","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00439-008-0489-5","volume":"123","author":"TL Assimes","year":"2008","unstructured":"Assimes TL, Knowles JW, Priest JR, Basu A, Volcik KA, Southwick A, et al. Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease. Hum Genet. 2008;123:399\u2013408. https:\/\/doi.org\/10.1007\/s00439-008-0489-5.","journal-title":"Hum Genet"},{"key":"867_CR85","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/j.1398-9995.2008.01667.x","volume":"63","author":"JW Holloway","year":"2008","unstructured":"Holloway JW, Barton SJ, Holgate ST, Rose-Zerilli MJ, Sayers I. The role of LTA4H and ALOX5AP polymorphism in asthma and allergy susceptibility. Allergy. 2008;63:1046\u201353. https:\/\/doi.org\/10.1111\/j.1398-9995.2008.01667.x.","journal-title":"Allergy"},{"key":"867_CR86","first-page":"362","volume":"34","author":"C Cai","year":"2011","unstructured":"Cai C, Zhou MX, Li YP, Chen CS. Association of leukotriene gene polymorphisms with response to antileukotriene treatment in patients with asthma. Zhonghua Jie He He Hu Xi Za Zhi. 2011;34:362\u20136.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"867_CR87","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1365-2222.2009.03438.x","volume":"40","author":"M Via","year":"2010","unstructured":"Via M, De Giacomo A, Corvol H, Eng C, Seibold MA, Gillett C, et al. The role of LTA4H and ALOX5AP genes in the risk for asthma in Latinos. Clin Exp Allergy. 2010;40:582\u20139. https:\/\/doi.org\/10.1111\/j.1365-2222.2009.03438.x.","journal-title":"Clin Exp Allergy"},{"key":"867_CR88","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jaci.2010.06.048","volume":"126","author":"H Tcheurekdjian","year":"2010","unstructured":"Tcheurekdjian H, Via M, De Giacomo A, Corvol H, Eng C, Thyne S, et al. ALOX5AP and LTA4H polymorphisms modify augmentation of bronchodilator responsiveness by leukotriene modifiers in Latinos. J Allergy Clin Immunol. 2010;126:853\u20138. https:\/\/doi.org\/10.1016\/j.jaci.2010.06.048.","journal-title":"J Allergy Clin Immunol"},{"key":"867_CR89","doi-asserted-by":"publisher","unstructured":"F. Mei, Y.F. Wang, D. Yang, R.X. Zuo, T. Shen, T.H. Yang, Y.L. Sa, [Relationship between Polymorphism in ALOX5, ALOX5AP and Susceptibility to Myeloid Leukemia], Zhongguo Shi Yan Xue Ye Xue Za Zhi 28 (2020) 40\u201350. https:\/\/doi.org\/10.19746\/j.cnki.issn.1009-2137.2020.01.008.","DOI":"10.19746\/j.cnki.issn.1009-2137.2020.01.008"},{"key":"867_CR90","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/170153","volume":"2010","author":"KP Burdon","year":"2010","unstructured":"Burdon KP, Rudock ME, Lehtinen AB, Langefeld CD, Bowden DW, Register TC, et al. Human lipoxygenase pathway gene variation and association with markers of subclinical atherosclerosis in the diabetes heart study. Mediators Inflamm. 2010;2010:170153. https:\/\/doi.org\/10.1155\/2010\/170153.","journal-title":"Mediators Inflamm"},{"key":"867_CR91","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jns.2016.01.022","volume":"362","author":"O \u0160er\u00fd","year":"2016","unstructured":"\u0160er\u00fd O, Hlineck\u00e1 L, Povov\u00e1 J, Bonczek O, Zeman T, Janout V, et al. Arachidonate 5-lipoxygenase (ALOX5) gene polymorphism is associated with Alzheimer\u2019s disease and body mass index. J Neurol Sci. 2016;362:27\u201332. https:\/\/doi.org\/10.1016\/j.jns.2016.01.022.","journal-title":"J Neurol Sci"},{"key":"867_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106596","volume":"9","author":"G He","year":"2014","unstructured":"He G, Ye S, Hui J, Shen D, Qi C, Xu L, et al. Interrelationships between ALOX5AP polymorphisms, serum leukotriene B4 level and risk of acute coronary syndrome. PLoS ONE. 2014;9:e106596. https:\/\/doi.org\/10.1371\/journal.pone.0106596.","journal-title":"PLoS ONE"},{"key":"867_CR93","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3892\/etm.2016.3334","volume":"12","author":"M Postula","year":"2016","unstructured":"Postula M, Janicki PK, Rosiak M, Eyileten C, Zaremba M, Kaplon-Cieslicka A, et al. Targeted deep resequencing of ALOX5 and ALOX5AP in patients with diabetes and association of rare variants with leukotriene pathways. Exp Ther Med. 2016;12:415\u201321. https:\/\/doi.org\/10.3892\/etm.2016.3334.","journal-title":"Exp Ther Med"},{"key":"867_CR94","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/ng1311","volume":"36","author":"A Helgadottir","year":"2004","unstructured":"Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet. 2004;36:233\u20139. https:\/\/doi.org\/10.1038\/ng1311.","journal-title":"Nat Genet"},{"key":"867_CR95","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11936-006-0011-0","volume":"8","author":"H Hakonarson","year":"2006","unstructured":"Hakonarson H. Role of FLAP and PDE4D in myocardial infarction and stroke: target discovery and future treatment options. Curr Treat Options Cardiovasc Med. 2006;8:183\u201392. https:\/\/doi.org\/10.1007\/s11936-006-0011-0.","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"867_CR96","doi-asserted-by":"publisher","unstructured":"O.M. Dekkers, Meta\u2010analysis: Key features, potentials and misunderstandings, Research and Practice in Thrombosis and Haemostasis 2 (2018) 658\u2013663. https:\/\/doi.org\/10.1002\/rth2.12153.","DOI":"10.1002\/rth2.12153"},{"key":"867_CR97","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12920-024-01991-8","volume":"17","author":"P Song","year":"2024","unstructured":"Song P, Deng H, Liu Y, Zhang M. Integrated bioinformatics analysis and experimental validation reveal the relationship between ALOX5AP and the prognosis and immune microenvironment in glioma. BMC Med Genomics. 2024;17:218. https:\/\/doi.org\/10.1186\/s12920-024-01991-8.","journal-title":"BMC Med Genomics"},{"key":"867_CR98","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s13018-023-03919-x","volume":"18","author":"GD Han","year":"2023","unstructured":"Han GD, Dai J, Hui HX, Zhu J. ALOX5AP suppresses osteosarcoma progression via Wnt\/\u03b2-catenin\/EMT pathway and associates with clinical prognosis and immune infiltration. J Orthop Surg Res. 2023;18:446. https:\/\/doi.org\/10.1186\/s13018-023-03919-x.","journal-title":"J Orthop Surg Res"},{"key":"867_CR99","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12920-025-02188-3","volume":"18","author":"D Yin","year":"2025","unstructured":"Yin D, Guo Q, Jiang H, Hu Y, Liu L, Li X, et al. Single-cell sequencing-based study of ferroptosis mechanisms in heat stroke: identification of key biomarkers and dynamic analysis of the immune microenvironment. BMC Med Genomics. 2025;18:124. https:\/\/doi.org\/10.1186\/s12920-025-02188-3.","journal-title":"BMC Med Genomics"},{"key":"867_CR100","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/1479164118756241","volume":"15","author":"XA Tsekmekidou","year":"2018","unstructured":"Tsekmekidou XA, Kotsa KD, Tsetsos FS, Didangelos TP, Georgitsi MA, Roumeliotis AK, et al. Assessment of association between lipoxygenase genes variants in elderly Greek population and type 2 diabetes mellitus. Diab Vasc Dis Res. 2018;15:340\u20133. https:\/\/doi.org\/10.1177\/1479164118756241.","journal-title":"Diab Vasc Dis Res"},{"key":"867_CR101","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/pgpm.S352225","volume":"15","author":"Z Xiao","year":"2022","unstructured":"Xiao Z, Zhao H. Ferroptosis-related APOE, BCL3 and ALOX5AP gene polymorphisms are associated with the risk of thyroid cancer. Pharmgenomics Pers Med. 2022;15:157\u201365. https:\/\/doi.org\/10.2147\/pgpm.S352225.","journal-title":"Pharmgenomics Pers Med"},{"key":"867_CR102","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3389\/fcell.2020.00453","volume":"8","author":"X Li","year":"2020","unstructured":"Li X, Shi W, Zhang R, Zhang S, Hou W, Wu Y, et al. Integrate molecular phenome and polygenic interaction to detect the genetic risk of ischemic stroke. Front Cell Dev Biol. 2020;8:453. https:\/\/doi.org\/10.3389\/fcell.2020.00453.","journal-title":"Front Cell Dev Biol"},{"key":"867_CR103","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.plefa.2011.07.004","volume":"85","author":"DH Kim","year":"2011","unstructured":"Kim DH, Ahn WY, Kim DK, Choe BK, Kim SK, Jo DJ, et al. A promoter polymorphism (rs17222919, \u20131316T\/G) of ALOX5AP is associated with intracerebral hemorrhage in Korean population. Prostaglandins Leukot Essent Fatty Acids. 2011;85:115\u201320. https:\/\/doi.org\/10.1016\/j.plefa.2011.07.004.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"867_CR104","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.gene.2014.07.007","volume":"548","author":"A Papapostolou","year":"2014","unstructured":"Papapostolou A, Spengos K, Fylaktou I, Poulou M, Gountas I, Kitsiou-Tzeli S, et al. Are ALOX5AP gene SNPs a risk or protective factor for stroke? Gene. 2014;548:56\u201360. https:\/\/doi.org\/10.1016\/j.gene.2014.07.007.","journal-title":"Gene"},{"key":"867_CR105","first-page":"801","volume":"21","author":"Y Yamada","year":"2008","unstructured":"Yamada Y, Kato K, Oguri M, Yoshida T, Yokoi K, Watanabe S, et al. Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome. Int J Mol Med. 2008;21:801\u20138.","journal-title":"Int J Mol Med"},{"key":"867_CR106","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/358076","volume":"2012","author":"G Andreotti","year":"2012","unstructured":"Andreotti G, Koutros S, Berndt SI, Hughes Barry K, Hou L, Hoppin JA, et al. The interaction between pesticide use and genetic variants involved in lipid metabolism on prostate cancer risk. J Cancer Epidemiol. 2012;2012:358076. https:\/\/doi.org\/10.1155\/2012\/358076.","journal-title":"J Cancer Epidemiol"},{"key":"867_CR107","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1159\/000482023","volume":"43","author":"D Liu","year":"2017","unstructured":"Liu D, Liu L, Song Z, Hu Z, Liu J, Hou D. Genetic variations of oxidative stress related genes ALOX5, ALOX5AP and MPO modulate ischemic stroke susceptibility through main effects and epistatic interactions in a Chinese population. Cell Physiol Biochem. 2017;43:1588\u2013602. https:\/\/doi.org\/10.1159\/000482023.","journal-title":"Cell Physiol Biochem"},{"key":"867_CR108","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12263-012-0302-x","volume":"8","author":"N Habermann","year":"2013","unstructured":"Habermann N, Ulrich CM, Lundgreen A, Makar KW, Poole EM, Caan B, et al. PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer. Genes Nutr. 2013;8:115\u201326. https:\/\/doi.org\/10.1007\/s12263-012-0302-x.","journal-title":"Genes Nutr"},{"key":"867_CR109","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1177\/1479164118755044","volume":"15","author":"D Liu","year":"2018","unstructured":"Liu D, Liu L, Hu Z, Song Z, Wang Y, Chen Z. Evaluation of the oxidative stress-related genes ALOX5, ALOX5AP, GPX1, GPX3 and MPO for contribution to the risk of type 2 diabetes mellitus in the Han Chinese population. Diab Vasc Dis Res. 2018;15:336\u20139. https:\/\/doi.org\/10.1177\/1479164118755044.","journal-title":"Diab Vasc Dis Res"},{"key":"867_CR110","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.plefa.2012.09.005","volume":"87","author":"G Wang","year":"2012","unstructured":"Wang G, Zhang J, Sun H, Cao W, Zhang J, Wang Y, et al. Genetic variation in members of the leukotrienes biosynthesis pathway confers risk of ischemic stroke in Eastern Han Chinese. Prostaglandins Leukot Essent Fatty Acids. 2012;87:169\u201375. https:\/\/doi.org\/10.1016\/j.plefa.2012.09.005.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"867_CR111","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/gcc.22042","volume":"52","author":"SE Kleinstein","year":"2013","unstructured":"Kleinstein SE, Heath L, Makar KW, Poole EM, Seufert BL, Slattery ML, et al. Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia. Genes Chromosomes Cancer. 2013;52:437\u201349. https:\/\/doi.org\/10.1002\/gcc.22042.","journal-title":"Genes Chromosomes Cancer"},{"key":"867_CR112","doi-asserted-by":"publisher","first-page":"R81","DOI":"10.1186\/bcr3475","volume":"15","author":"S Chung","year":"2013","unstructured":"Chung S, Low SK, Zembutsu H, Takahashi A, Kubo M, Sasa M, et al. A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients. Breast Cancer Res. 2013;15:R81. https:\/\/doi.org\/10.1186\/bcr3475.","journal-title":"Breast Cancer Res"},{"key":"867_CR113","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1365-3083.2012.02712.x","volume":"76","author":"M Ro","year":"2012","unstructured":"Ro M, Kim S, Pyun JA, Shin C, Cho NH, Lee JY, et al. Association between arachidonate 5-lipoxygenase-activating protein (ALOX5AP) and lung function in a Korean population. Scand J Immunol. 2012;76:151\u20137. https:\/\/doi.org\/10.1111\/j.1365-3083.2012.02712.x.","journal-title":"Scand J Immunol"},{"key":"867_CR114","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1471-2350-13-110","volume":"13","author":"AS Tulah","year":"2012","unstructured":"Tulah AS, Begh\u00e9 B, Barton SJ, Holloway JW, Sayers I. Leukotriene B4 receptor locus gene characterisation and association studies in asthma. BMC Med Genet. 2012;13:110. https:\/\/doi.org\/10.1186\/1471-2350-13-110.","journal-title":"BMC Med Genet"},{"key":"867_CR115","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2350-12-173","volume":"12","author":"AS Tulah","year":"2011","unstructured":"Tulah AS, Parker SG, Moffatt MF, Wardlaw AJ, Connolly MJ, Sayers I. The role of ALOX5AP, LTA4H and LTB4R polymorphisms in determining baseline lung function and COPD susceptibility in UK smokers. BMC Med Genet. 2011;12:173. https:\/\/doi.org\/10.1186\/1471-2350-12-173.","journal-title":"BMC Med Genet"},{"key":"867_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00191","volume":"4","author":"JR Dungan","year":"2013","unstructured":"Dungan JR, Hauser ER, Qin X, Kraus WE. The genetic basis for survivorship in coronary artery disease. Front Genet. 2013;4:191. https:\/\/doi.org\/10.3389\/fgene.2013.00191.","journal-title":"Front Genet"},{"key":"867_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144551","volume":"741","author":"I Cilen\u0161ek","year":"2020","unstructured":"Cilen\u0161ek I, \u0160eruga M, Makuc J, Zavr\u0161nik M, Petrovi\u010d D. The ALOXA5AP gene (rs38022789) is associated with diabetic nephropathy in Slovenian patients with type 2 diabetes mellitus. Gene. 2020;741:144551. https:\/\/doi.org\/10.1016\/j.gene.2020.144551.","journal-title":"Gene"},{"key":"867_CR118","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3892\/ijmm_00000161","volume":"23","author":"T Yoshida","year":"2009","unstructured":"Yoshida T, Kato K, Yokoi K, Watanabe S, Metoki N, Yoshida H, et al. Association of genetic variants with chronic kidney disease in Japanese individuals with type 2 diabetes mellitus. Int J Mol Med. 2009;23:529\u201337. https:\/\/doi.org\/10.3892\/ijmm_00000161.","journal-title":"Int J Mol Med"},{"key":"867_CR119","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1253\/circj.69.1029","volume":"69","author":"K Kajimoto","year":"2005","unstructured":"Kajimoto K, Shioji K, Ishida C, Iwanaga Y, Kokubo Y, Tomoike H, et al. Validation of the association between the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a Japanese population. Circ J. 2005;69:1029\u201334. https:\/\/doi.org\/10.1253\/circj.69.1029.","journal-title":"Circ J"},{"key":"867_CR120","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ajh.21048","volume":"83","author":"P Sebastiani","year":"2008","unstructured":"Sebastiani P, Wang L, Nolan VG, Melista E, Ma Q, Baldwin CT, et al. Fetal hemoglobin in sickle cell anemia: bayesian modeling of genetic associations. Am J Hematol. 2008;83:189\u201395. https:\/\/doi.org\/10.1002\/ajh.21048.","journal-title":"Am J Hematol"},{"key":"867_CR121","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/1099800407313385","volume":"9","author":"SF Wung","year":"2008","unstructured":"Wung SF, Aouizerat BE. Candidate genes of the 5-lipoxygenase pathway in acute coronary syndrome: a pilot study. Biol Res Nurs. 2008;9:280\u201392. https:\/\/doi.org\/10.1177\/1099800407313385.","journal-title":"Biol Res Nurs"},{"key":"867_CR122","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/fpc.0000000000000016","volume":"24","author":"J Knights","year":"2014","unstructured":"Knights J, Sato Y, Kaniwa N, Saito Y, Ueno H, Ramanathan M. Genetic factors associated with gemcitabine pharmacokinetics, disposition, and toxicity. Pharmacogenet Genomics. 2014;24:15\u201325. https:\/\/doi.org\/10.1097\/fpc.0000000000000016.","journal-title":"Pharmacogenet Genomics"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00867-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-025-00867-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00867-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T12:53:38Z","timestamp":1768913618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40246-025-00867-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":122,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["867"],"URL":"https:\/\/doi.org\/10.1186\/s40246-025-00867-x","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate:"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication:"}},{"value":"There are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}